 |
市场调查报告书
商品编码
1672922
动物抗生素市场按药物类型、剂型、动物类型和地区划分Veterinary Antibiotics Market, By Drug Type, By Dosage Form, By Animal Type, By Geography |
||||||
2025 年全球兽用抗生素市场规模估计为 41.8 亿美元，预计到 2032 年将达到 55.1 亿美元，2025 年至 2032 年的复合年增长率为 4.0%。
| 报告范围 | 报告详细信息 | ||
|---|---|---|---|
| 基准年 | 2024 | 2025 年市场规模 | 41.8亿美元 |
| 效能资料 | 从 2020 年到 2024 年 | 预测期 | 2025 至 2032 年 |
| 预测期：2025-2032年复合年增长率： | 4.00％ | 2032 年价值预测 | 55.1亿美元 |
由于动物保健支出的增加和通用感染疾病的流行，兽用抗生素市场正在经历显着增长。畜牧业的发展，特别是已开发地区的畜牧业发展，推动了对抗生素的需求，用于预防和治疗伴同性动物的各种感染疾病。此外，生活方式的改变和对富含动物性蛋白质的饮食的日益重视，正在重振世界各地的肉类生产。大规模畜牧生产需要适当使用抗生素来促进肉类动物的生长并预防疾病。
市场动态
牲畜食品消费的增加可能会推动兽用抗生素市场的成长。根据联合国粮食及农业组织 2019 年的数据，预计 2020 年至 2030 年间全球肉类产量将成长约 15%。然而，畜牧业中抗生素的过度使用和滥用导致了抗生素抗药性，阻碍了市场的成长。包括噬菌体和益生菌在内的替代治疗选择对市场相关人员来说代表着巨大的机会。开发中国家兽医保健基础设施的发展可能在不久的将来为抗生素製造商开闢新的途径。
本研究的主要特点
本报告对全球兽用抗生素市场进行了详细分析，并提供了预测期（2025-2032 年）的市场规模（十亿美元）和年复合成长率（CAGR%），假设基准年为 2024 年。
它还强调了各个领域的潜在商机并解释了该市场的有吸引力的投资提案矩阵。
它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
全球动物抗生素市场的主要企业根据公司亮点、产品系列、关键亮点、绩效和策略等参数进行分析。
研究中介绍的主要企业包括 Merck &Co., Inc.、Ceva Sante Animale、Zoetis、Boehringer Ingelheim International GmbH、Dechra Pharmaceuticals、Elanco Animal Health Incorporated、Virbac SA、Bimeda, Inc.、Vetoquinniol、Zydus Corporation Incorporated、Virbac SA、Bimeda, Inc.、Vetoquinniol、Zydus Corporation Abromal、Blackmal Corporation Abrocier Health、Amal。
本报告的见解可以帮助负责人和公司经营团队就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球动物抗生素市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
相关人员可以透过分析全球动物抗生素市场所使用的各种策略矩阵来促进决策。
目录
第一章 调查目的与前提条件
- 研究目标
- 先决条件
- 简称
第二章 市场展望
- 报告描述
- 市场定义和范围
- 执行摘要
第三章市场动态、法规与趋势分析
- 市场动态
- 影响分析
- 主要亮点
- 监管情景
- 产品发布/核准
- PEST分析
- PORTER 分析
- 併购情景
- 流行病学
4. 动物抗生素市场，依药物类型，2020-2032 年（十亿美元）
- Aminoglycosides
- β-内酰胺类抗生素
- 氯霉素
- Fluoroquinolones
- 糖肽
- 林可酰胺类
- 大环内酯类
- 多粘菌素
- 四环霉素
- 其他的
5. 动物抗生素市场，按剂型，2020-2032 年（十亿美元）
- 粉末
- 解决方案
- 注射
- 其他的
6. 2020-2032 年动物抗生素市场（以动物类型划分）（十亿美元）
- 伴同性
- 狗
- 猫
- 家畜
- 牛
- 羊
- 猪
- 其他（家禽等）
7. 动物抗生素市场，按地区，2020-2032 年（十亿美元）
- 北美洲
- 拉丁美洲
- 欧洲
- 亚太地区
- 中东
- 非洲
第八章 竞争格局
- Merck & Co., Inc.
- Ceva Sante Animale
- Zoetis
- Boehringer Ingelheim International GmbH
- Dechra Pharmaceuticals
- Elanco Animal Health Incorporated
- Virbac SA
- Bimeda, Inc.
- Vetoquinol
- Zydus Animal Health
- Blacksmith Medicines
- Inovet
- Calier
- Phibro Animal Health Corporation
第九章分析师建议
- 机会
- 分析师观点
- Coherent Opportunity Map
第十章参考文献与调查方法
- 参考
- 调查方法
- 关于出版商
Global Veterinary Antibiotics Market is estimated to be valued at USD 4.18 Bn in 2025 and is expected to reach USD 5.51 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.0% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 4.18 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 4.00% | 2032 Value Projection: | USD 5.51 Bn |
Veterinary antibiotics market has witnessed significant growth due to rising animal healthcare expenditure and increasing prevalence of zoonotic diseases. Growing animal adoption, particularly in developed regions, has also boosted demand for antibiotics to prevent and treat various infections in companion animals. Moreover, changing lifestyles and increasing focus on protein-rich diets from animal sources have revved up meat production across the globe. Large scale livestock production practices necessitate the proper use of antibiotics to promote growth and prevent diseases in animals reared for meat consumption.
Market Dynamics
Rising consumption of livestock-derived food products can drive the veterinary antibiotics market growth. In 2019, according to the United Nations Food and Agriculture Organization, global meat production is projected to grow approximately 15% in the period between 2020 and 2030. However, overuse and misuse of antibiotics in the livestock sector has led to antibiotic resistance, thus, hampering the market growth. Alternative treatment options including bacteriophages and probiotics present significant opportunities for market players. Growing veterinary healthcare infrastructure in developing nations can create new avenues for antibiotics manufacturers in the near future.
Key features of the study
This report provides in-depth analysis of the global veterinary antibiotics market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global veterinary antibiotics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Merck & Co., Inc., Ceva Sante Animale, Zoetis, Boehringer Ingelheim International GmbH, Dechra Pharmaceuticals, Elanco Animal Health Incorporated, Virbac S.A., Bimeda, Inc., Vetoquinol, Zydus Animal Health, Blacksmith Medicines, Inovet, Calier, and Phibro Animal Health Corporation
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global veterinary antibiotics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary antibiotics market
Market Segmentation
- By Drug Type Insights (Revenue, USD Bn, 2019 - 2032)
- Aminoglycosides
- B-Lactam Antibiotics
- Chloramphenicol
- Fluoroquinolones
- Glycopeptides
- Lincosamides
- Macrolides
- Polymixins
- Tetracyclines
- Others
- By Dosage Form Insights (Revenue, USD Bn, 2019 - 2032)
- Powder
- Solutions
- Injections
- Others
- By Animal Type Insights (Revenue, USD Bn, 2019 - 2032)
- Companion
- Canine
- Feline
- Livestock
- Bovine
- Ovine
- Porcine
- Others (Poultry, etc.)
- Regional Insights (Revenue, USD Bn, 2019 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Merck & Co., Inc.
- Ceva Sante Animale
- Zoetis
- Boehringer Ingelheim International GmbH
- Dechra Pharmaceuticals
- Elanco Animal Health Incorporated
- Virbac S.A.
- Bimeda, Inc.
- Vetoquinol
- Zydus Animal Health
- Blacksmith Medicines
- Inovet
- Calier
- Phibro Animal Health Corporation
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Veterinary Antibiotics Market, By Drug Type
- Veterinary Antibiotics Market, By Dosage Form
- Veterinary Antibiotics Market, By Animal Type
- Veterinary Antibiotics Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Epidemiology
4. Veterinary Antibiotics Market, By Drug Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Aminoglycosides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- B-Lactam Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Chloramphenicol
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Fluoroquinolones
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Glycopeptides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Lincosamides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Macrolides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Polymixins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Tetracyclines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Veterinary Antibiotics Market, By Dosage Form, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Powder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Solutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Injections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Veterinary Antibiotics Market, By Animal Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Companion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Canine
- Feline
- Livestock
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Bovine
- Ovine
- Porcine
- Others (Poultry, etc.)
7. Veterinary Antibiotics Market, By Region, 2020 - 2032, (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025,2028 & 2032, (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Dosage Form, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Animal Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Dosage Form, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Animal Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Dosage Form, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Animal Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Dosage Form, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Animal Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Dosage Form, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Animal Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Dosage Form, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Animal Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, (USD Bn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ceva Sante Animale
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Zoetis
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boehringer Ingelheim International GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Dechra Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Elanco Animal Health Incorporated
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Virbac S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bimeda, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Vetoquinol
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Zydus Animal Health
- Blacksmith Medicines
- Inovet
- Calier
- Phibro Animal Health Corporation
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us
动物抗生素市场按类别、动物类型、最终用户和治疗领域划分 - 2025-2030 年全球预测
宠物疫苗市场 - 全球产业规模、份额、趋势、机会和预测，按动物类型、按疫苗接种、按给药方式、按地区和竞争进行细分，2020-2030 年预测
宠物疫苗市场报告：趋势、预测和竞争分析（至 2031 年）
犬疫苗市场报告：趋势、预测和竞争分析（至 2031 年）
全球动物疫苗市场按动物类型、技术、给药途径、分销管道和地区划分
动物用疫苗的全球市场:市场规模·占有率·趋势，产业分析 (各类型·各产品·疾病·各给药途径·各流通管道·各地区)，未来预测 (2025年～2034年)
全球兽用疫苗市场（~2029）：种类（猪、家禽、家畜、伴同性动物）、科技（减毒、灭活、类毒素）、给药途径（肌肉、皮下、口服）、终端使用者（医院·诊所）分离
狗疫苗市场 - 全球产业规模、份额、趋势、机会和预测，按疫苗类型、疾病类型、免疫持续时间、给药途径、地区和竞争细分，2020-2030F
犬疫苗市场规模、份额、趋势分析报告：依疫苗类型、疾病类型、给药途径、免疫期、成分、地区、细分市场预测，2025-2030年
兽用疫苗市场规模、份额、成长分析、按产品、给药途径和地区 - 产业预测，2024-2031 年